Global Oncology Drugs Market Growth (Status and Outlook) 2023-2028

Report ID: 1162729 | Published Date: Jan 2025 | No. of Page: 124 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Oncology Drugs Market Size 2017-2028
        2.1.2 Oncology Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Oncology Drugs Segment by Type
        2.2.1 Chemotherapy
        2.2.2 Targeted Therapy
        2.2.3 Immunotherapy (Biologic Therapy)
        2.2.4 Hormonal Therapy
        2.2.5 Others
    2.3 Oncology Drugs Market Size by Type
        2.3.1 Oncology Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Oncology Drugs Market Size Market Share by Type (2017-2022)
    2.4 Oncology Drugs Segment by Application
        2.4.1 Blood Cancer
        2.4.2 Breast Cancer
        2.4.3 Gastrointestinal Cancer
        2.4.4 Prostate Cancer
        2.4.5 Respiratory or Lung Cancer
        2.4.6 Others
    2.5 Oncology Drugs Market Size by Application
        2.5.1 Oncology Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Oncology Drugs Market Size Market Share by Application (2017-2022)
3 Oncology Drugs Market Size by Player
    3.1 Oncology Drugs Market Size Market Share by Players
        3.1.1 Global Oncology Drugs Revenue by Players (2020-2022)
        3.1.2 Global Oncology Drugs Revenue Market Share by Players (2020-2022)
    3.2 Global Oncology Drugs Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Oncology Drugs by Regions
    4.1 Oncology Drugs Market Size by Regions (2017-2022)
    4.2 Americas Oncology Drugs Market Size Growth (2017-2022)
    4.3 APAC Oncology Drugs Market Size Growth (2017-2022)
    4.4 Europe Oncology Drugs Market Size Growth (2017-2022)
    4.5 Middle East & Africa Oncology Drugs Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Oncology Drugs Market Size by Country (2017-2022)
    5.2 Americas Oncology Drugs Market Size by Type (2017-2022)
    5.3 Americas Oncology Drugs Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Oncology Drugs Market Size by Region (2017-2022)
    6.2 APAC Oncology Drugs Market Size by Type (2017-2022)
    6.3 APAC Oncology Drugs Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Oncology Drugs by Country (2017-2022)
    7.2 Europe Oncology Drugs Market Size by Type (2017-2022)
    7.3 Europe Oncology Drugs Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Oncology Drugs by Region (2017-2022)
    8.2 Middle East & Africa Oncology Drugs Market Size by Type (2017-2022)
    8.3 Middle East & Africa Oncology Drugs Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Oncology Drugs Market Forecast
    10.1 Global Oncology Drugs Forecast by Regions (2023-2028)
        10.1.1 Global Oncology Drugs Forecast by Regions (2023-2028)
        10.1.2 Americas Oncology Drugs Forecast
        10.1.3 APAC Oncology Drugs Forecast
        10.1.4 Europe Oncology Drugs Forecast
        10.1.5 Middle East & Africa Oncology Drugs Forecast
    10.2 Americas Oncology Drugs Forecast by Country (2023-2028)
        10.2.1 United States Oncology Drugs Market Forecast
        10.2.2 Canada Oncology Drugs Market Forecast
        10.2.3 Mexico Oncology Drugs Market Forecast
        10.2.4 Brazil Oncology Drugs Market Forecast
    10.3 APAC Oncology Drugs Forecast by Region (2023-2028)
        10.3.1 China Oncology Drugs Market Forecast
        10.3.2 Japan Oncology Drugs Market Forecast
        10.3.3 Korea Oncology Drugs Market Forecast
        10.3.4 Southeast Asia Oncology Drugs Market Forecast
        10.3.5 India Oncology Drugs Market Forecast
        10.3.6 Australia Oncology Drugs Market Forecast
    10.4 Europe Oncology Drugs Forecast by Country (2023-2028)
        10.4.1 Germany Oncology Drugs Market Forecast
        10.4.2 France Oncology Drugs Market Forecast
        10.4.3 UK Oncology Drugs Market Forecast
        10.4.4 Italy Oncology Drugs Market Forecast
        10.4.5 Russia Oncology Drugs Market Forecast
    10.5 Middle East & Africa Oncology Drugs Forecast by Region (2023-2028)
        10.5.1 Egypt Oncology Drugs Market Forecast
        10.5.2 South Africa Oncology Drugs Market Forecast
        10.5.3 Israel Oncology Drugs Market Forecast
        10.5.4 Turkey Oncology Drugs Market Forecast
        10.5.5 GCC Countries Oncology Drugs Market Forecast
    10.6 Global Oncology Drugs Forecast by Type (2023-2028)
    10.7 Global Oncology Drugs Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Roche
        11.1.1 Roche Company Information
        11.1.2 Roche Oncology Drugs Product Offered
        11.1.3 Roche Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Roche Main Business Overview
        11.1.5 Roche Latest Developments
    11.2 Celgene
        11.2.1 Celgene Company Information
        11.2.2 Celgene Oncology Drugs Product Offered
        11.2.3 Celgene Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Celgene Main Business Overview
        11.2.5 Celgene Latest Developments
    11.3 Novartis
        11.3.1 Novartis Company Information
        11.3.2 Novartis Oncology Drugs Product Offered
        11.3.3 Novartis Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Novartis Main Business Overview
        11.3.5 Novartis Latest Developments
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Information
        11.4.2 Bristol-Myers Squibb Oncology Drugs Product Offered
        11.4.3 Bristol-Myers Squibb Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Bristol-Myers Squibb Main Business Overview
        11.4.5 Bristol-Myers Squibb Latest Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Information
        11.5.2 Johnson & Johnson Oncology Drugs Product Offered
        11.5.3 Johnson & Johnson Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Johnson & Johnson Main Business Overview
        11.5.5 Johnson & Johnson Latest Developments
    11.6 Merck & Co.
        11.6.1 Merck & Co. Company Information
        11.6.2 Merck & Co. Oncology Drugs Product Offered
        11.6.3 Merck & Co. Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Merck & Co. Main Business Overview
        11.6.5 Merck & Co. Latest Developments
    11.7 AstraZeneca
        11.7.1 AstraZeneca Company Information
        11.7.2 AstraZeneca Oncology Drugs Product Offered
        11.7.3 AstraZeneca Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 AstraZeneca Main Business Overview
        11.7.5 AstraZeneca Latest Developments
    11.8 Pfizer
        11.8.1 Pfizer Company Information
        11.8.2 Pfizer Oncology Drugs Product Offered
        11.8.3 Pfizer Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Pfizer Main Business Overview
        11.8.5 Pfizer Latest Developments
    11.9 Amgen
        11.9.1 Amgen Company Information
        11.9.2 Amgen Oncology Drugs Product Offered
        11.9.3 Amgen Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Amgen Main Business Overview
        11.9.5 Amgen Latest Developments
    11.10 Eli Lilly
        11.10.1 Eli Lilly Company Information
        11.10.2 Eli Lilly Oncology Drugs Product Offered
        11.10.3 Eli Lilly Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Eli Lilly Main Business Overview
        11.10.5 Eli Lilly Latest Developments
    11. AbbVie
        11.11.1 AbbVie Company Information
        11.11.2 AbbVie Oncology Drugs Product Offered
        11.11.3 AbbVie Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 AbbVie Main Business Overview
        11.11.5 AbbVie Latest Developments
    11.12 Takeda
        11.12.1 Takeda Company Information
        11.12.2 Takeda Oncology Drugs Product Offered
        11.12.3 Takeda Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Takeda Main Business Overview
        11.12.5 Takeda Latest Developments
    11.13 Astellas
        11.13.1 Astellas Company Information
        11.13.2 Astellas Oncology Drugs Product Offered
        11.13.3 Astellas Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Astellas Main Business Overview
        11.13.5 Astellas Latest Developments
    11.14 Ipsen
        11.14.1 Ipsen Company Information
        11.14.2 Ipsen Oncology Drugs Product Offered
        11.14.3 Ipsen Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Ipsen Main Business Overview
        11.14.5 Ipsen Latest Developments
    11.15 Sanofi
        11.15.1 Sanofi Company Information
        11.15.2 Sanofi Oncology Drugs Product Offered
        11.15.3 Sanofi Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Sanofi Main Business Overview
        11.15.5 Sanofi Latest Developments
    11.16 Bayer
        11.16.1 Bayer Company Information
        11.16.2 Bayer Oncology Drugs Product Offered
        11.16.3 Bayer Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Bayer Main Business Overview
        11.16.5 Bayer Latest Developments
    11.17 Biogen Idec
        11.17.1 Biogen Idec Company Information
        11.17.2 Biogen Idec Oncology Drugs Product Offered
        11.17.3 Biogen Idec Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Biogen Idec Main Business Overview
        11.17.5 Biogen Idec Latest Developments
    11.18 Teva
        11.18.1 Teva Company Information
        11.18.2 Teva Oncology Drugs Product Offered
        11.18.3 Teva Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 Teva Main Business Overview
        11.18.5 Teva Latest Developments
    11.19 Otsuka
        11.19.1 Otsuka Company Information
        11.19.2 Otsuka Oncology Drugs Product Offered
        11.19.3 Otsuka Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 Otsuka Main Business Overview
        11.19.5 Otsuka Latest Developments
    11.20 Eisai
        11.20.1 Eisai Company Information
        11.20.2 Eisai Oncology Drugs Product Offered
        11.20.3 Eisai Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.20.4 Eisai Main Business Overview
        11.20.5 Eisai Latest Developments
    11.21 Merck KGaA
        11.21.1 Merck KGaA Company Information
        11.21.2 Merck KGaA Oncology Drugs Product Offered
        11.21.3 Merck KGaA Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.21.4 Merck KGaA Main Business Overview
        11.21.5 Merck KGaA Latest Developments
    11.22 Gilead Sciences
        11.22.1 Gilead Sciences Company Information
        11.22.2 Gilead Sciences Oncology Drugs Product Offered
        11.22.3 Gilead Sciences Oncology Drugs Revenue, Gross Margin and Market Share (2020-2022)
        11.22.4 Gilead Sciences Main Business Overview
        11.22.5 Gilead Sciences Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Oncology Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Chemotherapy
    Table 3. Major Players of Targeted Therapy
    Table 4. Major Players of Immunotherapy (Biologic Therapy)
    Table 5. Major Players of Hormonal Therapy
    Table 6. Major Players of Others
    Table 7. Oncology Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Oncology Drugs Market Size by Type (2017-2022) & ($ Millions)
    Table 9. Global Oncology Drugs Market Size Market Share by Type (2017-2022)
    Table 10. Oncology Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Oncology Drugs Market Size by Application (2017-2022) & ($ Millions)
    Table 12. Global Oncology Drugs Market Size Market Share by Application (2017-2022)
    Table 13. Global Oncology Drugs Revenue by Players (2020-2022) & ($ Millions)
    Table 14. Global Oncology Drugs Revenue Market Share by Player (2020-2022)
    Table 15. Oncology Drugs Key Players Head office and Products Offered
    Table 16. Oncology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Oncology Drugs Market Size by Regions 2017-2022 & ($ Millions)
    Table 20. Global Oncology Drugs Market Size Market Share by Regions (2017-2022)
    Table 21. Americas Oncology Drugs Market Size by Country (2017-2022) & ($ Millions)
    Table 22. Americas Oncology Drugs Market Size Market Share by Country (2017-2022)
    Table 23. Americas Oncology Drugs Market Size by Type (2017-2022) & ($ Millions)
    Table 24. Americas Oncology Drugs Market Size Market Share by Type (2017-2022)
    Table 25. Americas Oncology Drugs Market Size by Application (2017-2022) & ($ Millions)
    Table 26. Americas Oncology Drugs Market Size Market Share by Application (2017-2022)
    Table 27. APAC Oncology Drugs Market Size by Region (2017-2022) & ($ Millions)
    Table 28. APAC Oncology Drugs Market Size Market Share by Region (2017-2022)
    Table 29. APAC Oncology Drugs Market Size by Type (2017-2022) & ($ Millions)
    Table 30. APAC Oncology Drugs Market Size Market Share by Type (2017-2022)
    Table 31. APAC Oncology Drugs Market Size by Application (2017-2022) & ($ Millions)
    Table 32. APAC Oncology Drugs Market Size Market Share by Application (2017-2022)
    Table 33. Europe Oncology Drugs Market Size by Country (2017-2022) & ($ Millions)
    Table 34. Europe Oncology Drugs Market Size Market Share by Country (2017-2022)
    Table 35. Europe Oncology Drugs Market Size by Type (2017-2022) & ($ Millions)
    Table 36. Europe Oncology Drugs Market Size Market Share by Type (2017-2022)
    Table 37. Europe Oncology Drugs Market Size by Application (2017-2022) & ($ Millions)
    Table 38. Europe Oncology Drugs Market Size Market Share by Application (2017-2022)
    Table 39. Middle East & Africa Oncology Drugs Market Size by Region (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Oncology Drugs Market Size Market Share by Region (2017-2022)
    Table 41. Middle East & Africa Oncology Drugs Market Size by Type (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Oncology Drugs Market Size Market Share by Type (2017-2022)
    Table 43. Middle East & Africa Oncology Drugs Market Size by Application (2017-2022) & ($ Millions)
    Table 44. Middle East & Africa Oncology Drugs Market Size Market Share by Application (2017-2022)
    Table 45. Key Market Drivers & Growth Opportunities of Oncology Drugs
    Table 46. Key Market Challenges & Risks of Oncology Drugs
    Table 47. Key Industry Trends of Oncology Drugs
    Table 48. Global Oncology Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 49. Global Oncology Drugs Market Size Market Share Forecast by Regions (2023-2028)
    Table 50. Global Oncology Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 51. Global Oncology Drugs Market Size Market Share Forecast by Type (2023-2028)
    Table 52. Global Oncology Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 53. Global Oncology Drugs Market Size Market Share Forecast by Application (2023-2028)
    Table 54. Roche Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 55. Roche Oncology Drugs Product Offered
    Table 56. Roche Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 57. Roche Main Business
    Table 58. Roche Latest Developments
    Table 59. Celgene Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 60. Celgene Oncology Drugs Product Offered
    Table 61. Celgene Main Business
    Table 62. Celgene Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 63. Celgene Latest Developments
    Table 64. Novartis Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 65. Novartis Oncology Drugs Product Offered
    Table 66. Novartis Main Business
    Table 67. Novartis Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 68. Novartis Latest Developments
    Table 69. Bristol-Myers Squibb Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 70. Bristol-Myers Squibb Oncology Drugs Product Offered
    Table 71. Bristol-Myers Squibb Main Business
    Table 72. Bristol-Myers Squibb Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 73. Bristol-Myers Squibb Latest Developments
    Table 74. Johnson & Johnson Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 75. Johnson & Johnson Oncology Drugs Product Offered
    Table 76. Johnson & Johnson Main Business
    Table 77. Johnson & Johnson Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 78. Johnson & Johnson Latest Developments
    Table 79. Merck & Co. Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 80. Merck & Co. Oncology Drugs Product Offered
    Table 81. Merck & Co. Main Business
    Table 82. Merck & Co. Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 83. Merck & Co. Latest Developments
    Table 84. AstraZeneca Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 85. AstraZeneca Oncology Drugs Product Offered
    Table 86. AstraZeneca Main Business
    Table 87. AstraZeneca Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 88. AstraZeneca Latest Developments
    Table 89. Pfizer Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 90. Pfizer Oncology Drugs Product Offered
    Table 91. Pfizer Main Business
    Table 92. Pfizer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 93. Pfizer Latest Developments
    Table 94. Amgen Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 95. Amgen Oncology Drugs Product Offered
    Table 96. Amgen Main Business
    Table 97. Amgen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 98. Amgen Latest Developments
    Table 99. Eli Lilly Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 100. Eli Lilly Oncology Drugs Product Offered
    Table 101. Eli Lilly Main Business
    Table 102. Eli Lilly Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 103. Eli Lilly Latest Developments
    Table 104. AbbVie Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 105. AbbVie Oncology Drugs Product Offered
    Table 106. AbbVie Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 107. AbbVie Main Business
    Table 108. AbbVie Latest Developments
    Table 109. Takeda Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 110. Takeda Oncology Drugs Product Offered
    Table 111. Takeda Main Business
    Table 112. Takeda Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 113. Takeda Latest Developments
    Table 114. Astellas Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 115. Astellas Oncology Drugs Product Offered
    Table 116. Astellas Main Business
    Table 117. Astellas Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 118. Astellas Latest Developments
    Table 119. Ipsen Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 120. Ipsen Oncology Drugs Product Offered
    Table 121. Ipsen Main Business
    Table 122. Ipsen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 123. Ipsen Latest Developments
    Table 124. Sanofi Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 125. Sanofi Oncology Drugs Product Offered
    Table 126. Sanofi Main Business
    Table 127. Sanofi Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 128. Sanofi Latest Developments
    Table 129. Bayer Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 130. Bayer Oncology Drugs Product Offered
    Table 131. Bayer Main Business
    Table 132. Bayer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 133. Bayer Latest Developments
    Table 134. Biogen Idec Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 135. Biogen Idec Oncology Drugs Product Offered
    Table 136. Biogen Idec Main Business
    Table 137. Biogen Idec Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 138. Biogen Idec Latest Developments
    Table 139. Teva Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 140. Teva Oncology Drugs Product Offered
    Table 141. Teva Main Business
    Table 142. Teva Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 143. Teva Latest Developments
    Table 144. Otsuka Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 145. Otsuka Oncology Drugs Product Offered
    Table 146. Otsuka Main Business
    Table 147. Otsuka Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 148. Otsuka Latest Developments
    Table 149. Eisai Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 150. Eisai Oncology Drugs Product Offered
    Table 151. Eisai Main Business
    Table 152. Eisai Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 153. Eisai Latest Developments
    Table 154. Merck KGaA Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 155. Merck KGaA Oncology Drugs Product Offered
    Table 156. Merck KGaA Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 157. Merck KGaA Main Business
    Table 158. Merck KGaA Latest Developments
    Table 159. Gilead Sciences Details, Company Type, Oncology Drugs Area Served and Its Competitors
    Table 160. Gilead Sciences Oncology Drugs Product Offered
    Table 161. Gilead Sciences Main Business
    Table 162. Gilead Sciences Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 163. Gilead Sciences Latest Developments
List of Figures
    Figure 1. Oncology Drugs Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Oncology Drugs Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Oncology Drugs Market Size Market Share by Type in 2021
    Figure 7. Oncology Drugs in Blood Cancer
    Figure 8. Global Oncology Drugs Market: Blood Cancer (2017-2022) & ($ Millions)
    Figure 9. Oncology Drugs in Breast Cancer
    Figure 10. Global Oncology Drugs Market: Breast Cancer (2017-2022) & ($ Millions)
    Figure 11. Oncology Drugs in Gastrointestinal Cancer
    Figure 12. Global Oncology Drugs Market: Gastrointestinal Cancer (2017-2022) & ($ Millions)
    Figure 13. Oncology Drugs in Prostate Cancer
    Figure 14. Global Oncology Drugs Market: Prostate Cancer (2017-2022) & ($ Millions)
    Figure 15. Oncology Drugs in Respiratory or Lung Cancer
    Figure 16. Global Oncology Drugs Market: Respiratory or Lung Cancer (2017-2022) & ($ Millions)
    Figure 17. Oncology Drugs in Others
    Figure 18. Global Oncology Drugs Market: Others (2017-2022) & ($ Millions)
    Figure 19. Global Oncology Drugs Market Size Market Share by Application in 2021
    Figure 20. Global Oncology Drugs Revenue Market Share by Player in 2021
    Figure 21. Global Oncology Drugs Market Size Market Share by Regions (2017-2022)
    Figure 22. Americas Oncology Drugs Market Size 2017-2022 ($ Millions)
    Figure 23. APAC Oncology Drugs Market Size 2017-2022 ($ Millions)
    Figure 24. Europe Oncology Drugs Market Size 2017-2022 ($ Millions)
    Figure 25. Middle East & Africa Oncology Drugs Market Size 2017-2022 ($ Millions)
    Figure 26. Americas Oncology Drugs Value Market Share by Country in 2021
    Figure 27. Americas Oncology Drugs Consumption Market Share by Type in 2021
    Figure 28. Americas Oncology Drugs Market Size Market Share by Application in 2021
    Figure 29. United States Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Canada Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 31. Mexico Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Brazil Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 33. APAC Oncology Drugs Market Size Market Share by Region in 2021
    Figure 34. APAC Oncology Drugs Market Size Market Share by Application in 2021
    Figure 35. China Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Japan Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 37. Korea Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 38. Southeast Asia Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 39. India Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Australia Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Europe Oncology Drugs Market Size Market Share by Country in 2021
    Figure 42. Europe Oncology Drugs Market Size Market Share by Type in 2021
    Figure 43. Europe Oncology Drugs Market Size Market Share by Application in 2021
    Figure 44. Germany Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 45. France Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 46. UK Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Italy Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 48. Russia Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Middle East & Africa Oncology Drugs Market Size Market Share by Region in 2021
    Figure 50. Middle East & Africa Oncology Drugs Market Size Market Share by Type in 2021
    Figure 51. Middle East & Africa Oncology Drugs Market Size Market Share by Application in 2021
    Figure 52. Egypt Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 53. South Africa Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 54. Israel Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 55. Turkey Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 56. GCC Country Oncology Drugs Market Size Growth 2017-2022 ($ Millions)
    Figure 57. Americas Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 58. APAC Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 59. Europe Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 60. Middle East & Africa Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 61. United States Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 62. Canada Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 63. Mexico Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 64. Brazil Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 65. China Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 66. Japan Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 67. Korea Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 68. Southeast Asia Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 69. India Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 70. Australia Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 71. Germany Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 72. France Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 73. UK Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 74. Italy Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 75. Russia Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 76. Spain Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 77. Egypt Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 78. South Africa Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 79. Israel Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 80. Turkey Oncology Drugs Market Size 2023-2028 ($ Millions)
    Figure 81. GCC Countries Oncology Drugs Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Oncology Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Oncology Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Oncology Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports